Skip to main content
Equibles

UBS Group AG

Position in ANRO — Alto Neuroscience, Inc.

CIK 1610520 ZURICH, V8
Back to ANRO Full portfolio

Position in ANRO

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,549,013
+$1,161,234 QoQ
Shares Held
58,697
+240.3% QoQ
Ownership
0.150%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#46
of 114 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ANRO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,806 across 561 Biotechnology names. ANRO ranks #235 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 5,450,825 $1,020,369,609
2 ROIV
Roivant Sciences Ltd.
 17,466,641 $618,144,423
3 PTGX
Protagonist Therapeutics, Inc
 3,399,221 $416,676,508
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 712,259 $353,800,411
5 MRNA
Moderna, Inc.
 4,463,211 $312,558,664
6 INSM
INSMED Inc
 2,584,446 $275,553,630
7 ABVX
Abivax S.A.
 1,844,918 $245,853,771
8 MDGL
Madrigal Pharmaceuticals, Inc.
 401,708 $215,697,109

All Filings in ANRO

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,549,013 58,697
2026-03-31 $387,779 17,250
2025-12-31 $329,103 18,489
2025-09-30 $558,904 139,031
2025-06-30 $942,074 428,216
2025-03-31 $1,102,052 510,210
2024-12-31 $1,702,138 402,397
2024-09-30 $400,490 35,008
2024-06-30 $28,756 2,690
2024-03-31 $13,308 867